Cr (VI) induces cell growth arrest through hydrogen peroxide-mediated reactions

  • Zhuo Zhang
  • Stephen S. Leonard
  • Suwei Wang
  • Val Vallyathan
  • Vince Castranova
  • Xianglin Shi
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 34)


Cr(VI) compounds are widely used in industries and are recognized human carcinogens. The mechanism of carcinogenesis associated with these compounds is not well understood. The present study focused on Cr (VI)-induced cell growth arrest in human lung epithelial A549 cells, using flow cytometric analysis of DNA content. Treatment of the cells with Cr (VI) at 1µM caused a growth arrest at G,/M phase. An increase in Cr (VI) concentration enhanced the growth arrest. At a concentration of 25 µM, Cr (VI)-induced apoptosis became apparent. Superoxide dismutase (SOD) or sodium formate did not alter the Cr (V I)-induced cell growth arrest. While catalase inhibited growth, indicating H2O, is an important mediator in Cr (VI)-induced G,/ M phase arrest. Electron spin resonance (ESR) spin trapping measurements showed that incubation of cells with Cr (VI) generated hydroxyl radical (’0H). Catalase inhibited the ‘OH radical generation, indicating that H_D2was generated from cells stimulated by Cr (VI), and that H02functioned as a precursor for-OH radical generation. The formation of 112O2from Cr (VI)-stimulated cells was also measured by the change in fluorescence of scopoletin in the presence of horseradish peroxidase. The mechanism of reactive oxygen species generation involved the reduction of molecular oxygen as shown by oxygen consumption assay. These results support the following conclusions: (a) Reactive oxygen species are generated in Cr (VI)-stimulatedA549 cells through reduction of molecular oxygen, (b) Among the reactive oxygen species generated, H2O2played a major role in causing G2/M phase arrest in human lung epithelial cells. (Mol Cell Biochem222:77-83,2001)


chromium cell cycle apoptosis reactive oxygen species 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Flora S, Serra D, BassoCZanaechi P: Mechanistic aspects of chromium carcinogenicity. Arch Toxicol 13(suppl): 28–39, 1989CrossRefGoogle Scholar
  2. 2.
    Freeman N, Stern AH, Lioy PJ: Exposure to chromium dust from homes in a chromium surveillance project. Arch Environ Health 52: 213–219, 1997PubMedCrossRefGoogle Scholar
  3. 3.
    World Health Organization. ‘ARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France, 1990Google Scholar
  4. 4.
    Enterline PE: Respiratory cancer among chromate workers. J Occup Med 16: 523–526, 1974PubMedGoogle Scholar
  5. 5.
    Norseth T: The carcinogenicity of chromium. Environ Health Perspect 40: 121–130, 1981PubMedCrossRefGoogle Scholar
  6. 6.
    De Flora S, Wetterhahn KE: Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 7: 169–244, 1989Google Scholar
  7. 7.
    Connett PH, Wetterhahn KE: Metabolism of the carcinogen chromate by cellular constituents. Struct Bonding 54: 93–124, 1983CrossRefGoogle Scholar
  8. 8.
    Venitt S, Levy L: Mutagenicity of chromates in bacteria and its relevance to chromate carcinogenicity. Nature 250: 493–495, 1974PubMedCrossRefGoogle Scholar
  9. 9.
    Shi X, Dalai NS: Role of superoxide radical in chromium (VI) generated hydroxyl radical: The Cr (VI) Haber-Weiss cycle. Arch Biochem Biophys 292: 323–327, 1992PubMedCrossRefGoogle Scholar
  10. 10.
    Jennette KE: Microsomal reduction of the carcinogen chromate reduces chromium (V). J Am Chem Soc 104: 874–875, 1982CrossRefGoogle Scholar
  11. 11.
    Aiyar J, Berkovits HJ, Floyd RA, Wetterhahn KE: Reaction of chromium (VI) with hydrogen peroxide in the presence of glutathione: Reactive intermediates and resulting DNA damage. Chem Res Toxicol 3: 595–6603, 1990PubMedCrossRefGoogle Scholar
  12. 12.
    Sugiyama M: Effects of vitamin E and vitamin B2 on chromate-induced DNA lesions. Biol Trace Element Res 21: 399–404, 1989Google Scholar
  13. 13.
    Kortenkamp A, Oeken G, Beyersmann D: The DNA cleavage induced by a chromium (V) complex and by chromate and glutathione is mediated by activated oxygen species. Mutat Res 232: 155–161, 1990PubMedCrossRefGoogle Scholar
  14. 14.
    Sugiyama M, Ando A, Ogura R: Effect of vitamin E on survival, glutathione reductase and formation of chromium (V) in Chinese Hamster V-79 cell treated with sodium chromate (VI). Carcinogenesis 10: 737–741,1989PubMedCrossRefGoogle Scholar
  15. 15.
    Shi X, Chiu A, Chen CT, Halliwell B, Castranova V, Vallyathan V: Reduction of chromium (Vl) and its relationship to carcinogenesis. J Toxicol Environ Health 2: 87–104, 1999Google Scholar
  16. 16.
    Leonard SS, Wang S, Zang L, Castranova V, Vallyathan V, Shi X: Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr (VI) reduction and its implication to Cr(VI)-induced carcinogencsis. J Environ Pathol Toxicol Oncol 19: 49–60, 2000PubMedGoogle Scholar
  17. 17.
    Shi X, Dalai NS: Hydroxyl radical generation in the NADHlmicrosomal reduction of vanadate. Free Rad Res Commun 17: 369–376, 1992CrossRefGoogle Scholar
  18. 18.
    Shi X, Dalai NS: Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem Biophys Res Commun 163: 627–6634, 1989PubMedCrossRefGoogle Scholar
  19. 19.
    Snyder RD: Role of active oxygen species in metal-induced DNA strand breakage in human diploid fibroblasts. Mutat Res 193: 237–246, 1988PubMedCrossRefGoogle Scholar
  20. 20.
    Shackelford RE, Kaufmann WK, Paules RS: Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 107: 5–24, 1999PubMedGoogle Scholar
  21. 2I.
    Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266: 1821–1828, 1994PubMedCrossRefGoogle Scholar
  22. 22.
    Mercer WE: Checking on the cell cycle. J Cell Biochem 30/31 (suppl): 50–54, 1998CrossRefGoogle Scholar
  23. 23.
    Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium (VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511–1517, 1996PubMedCrossRefGoogle Scholar
  24. 24.
    Bakke O, Jakobsen K, Eik-Nes KB: Concentration-dependent effects of potassium dichromate on the cell cycle. Cytometry 5: 482–486, 1984PubMedCrossRefGoogle Scholar
  25. 25.
    Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139: 271–279, 1991CrossRefGoogle Scholar
  26. 26.
    Sgonic R, Wick G: Methods for the detection of apoptosis. Int Arch Allergy Immunol 105: 327–332, 1994CrossRefGoogle Scholar
  27. 27.
    Rosen GM, Finkelstein E: Use of spin traps in biological systems. Adv Free Radical Biol Med 1: 345–375, 1985CrossRefGoogle Scholar
  28. 28.
    Leonard SS, Gannett PM, Rojanasakul Y, Schwegler-Berry D, Castranova V, Vallyathan V, Shi X: Cobalt-mediated generation of reactive oxygen species and its possible mechanism. J inorg Biochem 70: 239–244,1998PubMedCrossRefGoogle Scholar
  29. 29.
    Ye J, Zhang X, Young HA, Mao Y, Shi X: Chromium (VI)-induced nuclear factor-KB activation in intact cells via free radical reactions. Carcinogenesis 16: 2401–2405, 1995PubMedCrossRefGoogle Scholar
  30. 30.
    Chen F, Ding M, Lu Y, Leonard SS, Vallyathan V, Castranova V, Shi X: Participation of MAP kinasep38 and 1xB kinase in chromium (VI)-induced NF-kB and AP-1 activation. J Environ Pathol Toxicol Oncol 19: 231–238, 2000PubMedGoogle Scholar
  31. 31.
    Wang S, Leonard SS, Ye J, Ding M, Shi X: The role of hydroxyl radical as a messenger in Cr (VD-induced p53 activation. Am J Physiol 279: C868—C875, 2000Google Scholar
  32. 32.
    Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fisceila M, Jackman J, O’Connor PM, Anderson CW, Appella E: A p53-independent pathway for activation of WAF1/CIP, expression following oxidative stress. J Biol Chem 270: 29386–29391, 1995PubMedCrossRefGoogle Scholar
  33. 33.
    Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN: Molecular analysis ofH2O2- induced senescent-like growth arrest in normal human fibrosis: p53 and Rb control G, arrest but not cell replication. Biochem J 332: 43–50, 1998PubMedGoogle Scholar
  34. 34.
    Morgan DO: Principles ofCDK regulation, Nature 374: 13 l-134, 1995CrossRefGoogle Scholar
  35. 35.
    Draetta G: Cell cycle control in eukaryotes: Molecular mechanisms of Cdc2 activation. Trends Biochem Sci 15: 378–383, 1990PubMedCrossRefGoogle Scholar
  36. 36.
    Norbury C, Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441–470, 1993CrossRefGoogle Scholar
  37. 37.
    Pines J, Hunter T: isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58: 833–846, 1989PubMedCrossRefGoogle Scholar
  38. 38.
    Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonini J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V, Shi X: Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J Biol Chem 274: 34974–34980, 1999PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Zhuo Zhang
    • 1
    • 2
  • Stephen S. Leonard
    • 1
    • 2
  • Suwei Wang
    • 1
    • 2
  • Val Vallyathan
    • 1
    • 2
  • Vince Castranova
    • 1
    • 2
  • Xianglin Shi
    • 1
    • 2
  1. 1.Department of Basic Pharmaceutical SciencesWest Virginia UniversityMorgantown
  2. 2.Pathology and Physiology Research Branch, Health Effects Laboratory DivisionNational Institute for Occupational Safety and HealthMorgantownUSA

Personalised recommendations